Deferred Tax Assets, Valuation Allowance in USD of Fulgent Genetics, Inc. from Q4 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Fulgent Genetics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2017 to Q4 2024.
  • Fulgent Genetics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $22,702,000, a 43% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $22,702,000 +$6,802,000 +43% 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q4 2023 $15,900,000 +$13,068,000 +461% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $2,832,000 +$223,000 +8.5% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $2,609,000 +$588,000 +29% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $2,021,000 -$104,000 -4.9% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $2,125,000 +$677,000 +47% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q4 2018 $1,448,000 +$1,330,000 +1127% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 $118,000 31 Dec 2017 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.